We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Global Market for Women’s Health Devices Sees Moderate Growth

By HospiMedica International staff writers
Posted on 29 Nov 2015
Print article
The global market for women’s health devices is forecast to grow from an estimated USD 1.8 billion in 2014 to approximately USD 2.4 billion in 2021, representing a compound annual growth rate of 3.7%. These are the latest findings of GlobalData (London, United Kingdom), an international business intelligence provider.

The market encompasses treatments for conditions that are particular to the adult female anatomy; this includes abnormal uterine conditions, such as menorrhagia and uterine fibroids, pelvic disorders such as female stress urinary incontinence, and anti-conceptive procedures. Minimally invasive technologies to treat these conditions as alternatives to conventional surgery are expected to see increased adoption in the coming years, due to increased physician and patient awareness and an increasing number of women proactively seeking treatment.

Technologies include endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, and female urinary incontinence slings. As more women seek treatment for uterine health and incontinence issues, the market will become increasingly competitive, provided that the new technology meets efficacy and safety standards. However, recent lawsuits related to safety issues with some of these devices have received widespread media attention, particularly in the urinary incontinence sling market, causing some skepticism.

“The understanding that a woman’s quality of life can be vastly improved by new technologies coincides with the awareness that a variety of new treatment options, such as global endometrial ablation and uterine artery embolization, are far less invasive than surgery,” said GlobalData analyst Premdharan Meyyan. “For women who suffer from abnormal uterine conditions, such as heavy menstrual bleeding and uterine fibroids, these new technologies offer safe and effective alternative treatment options to patients who do not wish to undergo invasive surgery.”

Related Links:

GlobalData


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Vital Signs Monitor
Aurus 10

Print article

Channels

Surgical Techniques

view channel
Image: Miniaturized electric generators based on hydrogels for use in biomedical devices (Photo courtesy of HKU)

Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices

The development of engineered devices that can harvest and convert the mechanical motion of the human body into electricity is essential for powering bioelectronic devices. This mechanoelectrical energy... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.